In vitro task order evaluation of toxic profiles of tobacco additives in a systematic tiered approach
Ended Awarded Last action
- Contract number
- HHSF22301004T
- Awardee
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,552,162
Award facts
- Opportunity
-
- 900000000 Solicitation number
- Contract value 100% obligated
- $1,552,162.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Albuquerque, NM 87108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,552,162 |
About this award
This is a firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization, to conduct in vitro evaluation of the toxic profiles of tobacco additives in a systematic tiered approach. The contract has a ceiling value of $1,552,162.00 and an ultimate completion date of July 14, 2018. It was issued under the FDA's "In Vivo Toxicology of Tobacco 2015-2020" IDIQ contract, and does not have any set-aside designation. As a subsidiary of Lovelace Biomedical Research Institute, LBERI has over 70 years of expertise in inhalation toxicology, infectious disease modeling, and translational science, and has provided similar R&D services to various federal agencies, including NIH, NIAID, NCATS, and BARDA.
Quick answers
Who was awarded contract HHSF22301004T?
HHSF22301004T was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 14, 2016.
How much is contract HHSF22301004T worth?
The government has obligated $1,552,162 on HHSF22301004T.
Is contract HHSF22301004T an order under another contract?
Yes. HHSF22301004T is a delivery order under HHSF223201510001I, an indefinite delivery contract, on In Vivo Toxicology of Tobacco 2015-2020.
Was contract HHSF22301004T competed?
The extent of competition for HHSF22301004T was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award